These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14527092)

  • 1. Comparison of stepwise and simultaneous estimations of population pharmacokinetics and pharmacodynamics of TS-943.
    Furuya A; Kato N; Jingu S; Akimoto M; Kasai O; Suwa T; Sato M; Ogata H
    Eur J Drug Metab Pharmacokinet; 2003; 28(3):191-9. PubMed ID: 14527092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic analysis of TS-943, a selective non-peptide platelet glycoprotein-IIb/IIIa (GPIIb/IIIa) receptor antagonist, using a nonlinear mixed effect model in dogs.
    Furuya A; Nozawa M; Gotoh J; Jingu S; Akimoto M; Higuchi S; Suwa T; Ogata H
    J Pharm Pharmacol; 2002 Jul; 54(7):921-7. PubMed ID: 12162710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and pharmacodynamics of TS-943 for selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist in normal healthy subjects.
    Furuya A; Kato N; Jingu S; Akimoto M; Higuchi S; Suwa T; Ogata H
    Clin Pharmacol Ther; 2000 May; 67(5):489-97. PubMed ID: 10824627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and performance of a population pharmacokinetic model.
    Ette EI
    J Clin Pharmacol; 1997 Jun; 37(6):486-95. PubMed ID: 9208355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
    Proost JH; Schiere S; Eleveld DJ; Wierda JM
    Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis.
    Wählby U; Jonsson EN; Karlsson MO
    AAPS PharmSci; 2002; 4(4):E27. PubMed ID: 12645999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Evaluation of Population Pharmacokinetics and Pharmacodynamics in Linezolid-Induced Thrombocytopenia: The Transferability of Published Models to Different Hospitalized Patients.
    Ogami C; Tsuji Y; Nishi Y; Kawasuji H; To H; Yamamoto Y
    Ther Drug Monit; 2021 Apr; 43(2):271-278. PubMed ID: 33009290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
    Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
    Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited sampling models for simultaneous estimation of the pharmacokinetics of irinotecan and its active metabolite SN-38.
    Chabot GG
    Cancer Chemother Pharmacol; 1995; 36(6):463-72. PubMed ID: 7554037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine].
    Zuo XC; Yuan H; Zhang BK; Ng CM; Barrett JS; Yang GP; Huang ZJ; Pei Q; Guo R; Zhou YN; Jing NN; Di W
    Yao Xue Xue Bao; 2012 Jul; 47(7):941-6. PubMed ID: 22993862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic parameter estimation: population size versus number of samples.
    Girgis S; Pai SM; Girgis IG; Batra VK
    AAPS J; 2005 Oct; 7(2):46. PubMed ID: 16353905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction interval.
    Vozeh S; Uematsu T; Hauf GF; Follath F
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):203-12. PubMed ID: 4057058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.
    Johansson ÅM; Ueckert S; Plan EL; Hooker AC; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2014 Jun; 41(3):223-38. PubMed ID: 24801864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters.
    Ette EI; Kelman AW; Howie CA; Whiting B
    Ann Pharmacother; 1993 Sep; 27(9):1034-9. PubMed ID: 8117353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations.
    Goh BC; Fleming GF; Janisch L; Vogelzang NJ; Stadler WM; Ratain MJ
    Cancer Chemother Pharmacol; 2000; 45(6):489-94. PubMed ID: 10854137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mechanistically-based pharmacokinetic/pharmacodynamic models in drug development : a case study of a therapeutic protein.
    Marshall S; Macintyre F; James I; Krams M; Jonsson NE
    Clin Pharmacokinet; 2006; 45(2):177-97. PubMed ID: 16485916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitor.
    Gibbs JP; Emery MG; McCaffery I; Smith B; Gibbs MA; Akrami A; Rossi J; Paweletz K; Gastonguay MR; Bautista E; Wang M; Perfetti R; Daniels O
    J Clin Pharmacol; 2011 Jun; 51(6):830-41. PubMed ID: 20663992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.